Sickness Behaviors in Gynecologic Cancer Patients Treated with Chemotherapy

接受化疗的妇科癌症患者的疾病行为

基本信息

  • 批准号:
    8687616
  • 负责人:
  • 金额:
    $ 48.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Research has highlighted the prevalence and disruptiveness of fatigue, depression, and disruptions in sleep and physical activity (i.e., sickness behaviors) during chemotherapy. Biological mechanisms of sickness behaviors secondary to chemotherapy remain unknown, however. One potential biological mechanism of sickness behaviors is increased pro-inflammatory cytokines. Cross-sectional observational studies suggest that circulating pro-inflammatory cytokines are higher in post-treatment breast cancer survivors who experience chronic cancer-related fatigue. Despite these data, no studies have longitudinally examined the relationship between sickness behaviors and pro-inflammatory cytokines during and after chemotherapy. The trajectory and timing of pro-inflammatory cytokines relative to sickness behaviors is therefore unknown. Moreover, the components through which behavioral interventions exert beneficial effects on cytokines and sickness behaviors is unclear; one possibility is by increasing relaxed mood. The proposed project will assess fatigue, depression, sleep, activity, and circulating pro-inflammatory cytokines via self-report, actigraphy, and venipuncture in 150 gynecologic cancer patients receiving platinum- and taxane-based chemotherapy, one of the most arduous treatment regimens for cancer. Patients will be assessed the week before and the week after their first, third, and sixth chemotherapy infusions, as well as six and twelve months after chemotherapy ends. This study design will capture changes in sickness behaviors and cytokines on-treatment as well as in the early survivorship period. Patient participants who report clinically significant fatigue or depression a the twelve month assessment will participate in an experimental induction of relaxed mood to test the short-term effects of relaxation on cytokines and sickness behaviors. Because women without cancer also experience fatigue, depression, poor sleep, and reduced physical activity, and because data are sparse regarding normal fluctuations in circulating pro-inflammatory cytokines, the study will also assess sickness behaviors, and pro-inflammatory cytokines over a comparable time period in a sample of 150 women without cancer matched individually to patients based on age and zip code. The study will provide valuable information regarding the natural course of sickness behaviors and circulating pro-inflammatory cytokines in cancer patients treated with chemotherapy, including rates of change, temporal interrelationships, variation compared to women without cancer. In addition, it will determine whether induction of relaxation is an effective component of behavioral interventions to reduce sickness behaviors. These data will form the basis for future studies examining biobehavioral mechanisms of sickness behaviors and interventions to ameliorate them.
描述(由申请人提供):研究突出了化学疗法期间睡眠和体育锻炼(即疾病行为)的疲劳,抑郁和中断的患病率和破坏性。然而,疾病行为的生物学机制尚不清楚。疾病行为的一种潜在的生物学机制是增加促炎细胞因子。横断面观察性研究表明,在治疗后乳腺癌幸存者中经历慢性癌症相关疲劳的循环促炎细胞因子较高。尽管有这些数据,但在化学疗法期间和之后,没有研究纵向研究了疾病行为与促炎性细胞因子之间的关系。因此,促炎性细胞因子相对于疾病行为的轨迹和时机尚不清楚。此外,行为干预措施对细胞因子和疾病行为产生有益影响的组成部分尚不清楚。一种可能性是增加心情放松。拟议的项目将通过自我报告,行动术和静脉穿刺术评估疲劳,抑郁,睡眠,活动和循环促炎细胞因子,其中150名接受基于铂和紫杉烷化学疗法的妇科癌症患者,这是癌症最艰巨的治疗方案之一。患者将在第一周,第三和第六个化学疗法输注以及化学疗法结束后的六和十二个月后进行评估。这项研究设计将捕获疾病行为和细胞因子进行治疗以及早期生存期的变化。报告临床意义疲劳或抑郁症的患者参与者十二个月评估将参与放松情绪的实验诱导,以测试放松对细胞因子和疾病行为的短期影响。由于没有癌症的女性还会出现疲劳,抑郁症,睡眠不足和体育锻炼减少,并且由于循环促炎性细胞因子的正常波动的数据稀少,因此该研究还将评估150名与基于年龄和ZIP代码的患者相匹配的150名女性的疾病行为,而促炎性细胞因子在相当的情况下进行促炎性细胞因子。这项研究将提供有关疾病行为的自然过程和与没有癌症的女性相比,接受化学疗法治疗的癌症患者的自然过程和循环促炎细胞因子的循环促炎细胞因子。此外,它将确定放松的诱导是否是减少疾病行为的行为干预措施的有效组成部分。这些数据将构成研究疾病行为的生物行为机制的未来研究和改善它们的干预措施的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

HEATHER S.L. JIM的其他基金

Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison
嵌合抗原受体 T 细胞治疗后的神经认知和患者报告结果:对照比较
  • 批准号:
    10444276
    10444276
  • 财政年份:
    2022
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison
嵌合抗原受体 T 细胞治疗后的神经认知和患者报告结果:对照比较
  • 批准号:
    10656253
    10656253
  • 财政年份:
    2022
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Accelerated aging after chimeric antigen receptor T-cell therapy (CART): Leveraging a novel population of cancer survivors to elucidate mechanisms of dementia
嵌合抗原受体 T 细胞疗法 (CART) 后加速衰老:利用新型癌症幸存者群体来阐明痴呆机制
  • 批准号:
    10719874
    10719874
  • 财政年份:
    2022
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue
安非他酮治疗癌症相关疲劳的随机安慰剂对照试验
  • 批准号:
    10394730
    10394730
  • 财政年份:
    2018
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue
安非他酮治疗癌症相关疲劳的随机安慰剂对照试验
  • 批准号:
    10166792
    10166792
  • 财政年份:
    2018
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome
改善化疗引起恶心的预测:整合基因、行为和微生物组
  • 批准号:
    10166795
    10166795
  • 财政年份:
    2018
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome
改善化疗引起恶心的预测:整合基因、行为和微生物组
  • 批准号:
    10442417
    10442417
  • 财政年份:
    2018
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Internet-Assisted Cognitive Behavior Intervention for Targeted Therapy Fatigue
互联网辅助认知行为干预靶向治疗疲劳
  • 批准号:
    8990831
    8990831
  • 财政年份:
    2015
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Sickness Behaviors in Gynecologic Cancer Patients Treated with Chemotherapy
接受化疗的妇科癌症患者的疾病行为
  • 批准号:
    9093714
    9093714
  • 财政年份:
    2012
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Sickness Behaviors in Gynecologic Cancer Patients Treated with Chemotherapy
接受化疗的妇科癌症患者的疾病行为
  • 批准号:
    8515362
    8515362
  • 财政年份:
    2012
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:

相似国自然基金

基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
  • 批准号:
    51009131
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
  • 批准号:
    50178004
  • 批准年份:
    2001
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目

相似海外基金

A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
减少年轻成年睾丸癌幸存者不良后果的生物行为干预
  • 批准号:
    10736501
    10736501
  • 财政年份:
    2023
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Implementing Evidence-Based Treatment for Common Mental Disorders in HIV Clinics in Ukraine
在乌克兰艾滋病毒诊所对常见精神疾病实施循证治疗
  • 批准号:
    10762576
    10762576
  • 财政年份:
    2023
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
  • 批准号:
    10456380
    10456380
  • 财政年份:
    2023
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Multidomain Peptide Hydrogels as a Therapeutic Delivery Platform for Cancer Treatment
多域肽水凝胶作为癌症治疗的治疗传递平台
  • 批准号:
    10743144
    10743144
  • 财政年份:
    2023
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别:
Immunoregulatory Therapeutics for Ulcerative Colitis
溃疡性结肠炎的免疫调节治疗
  • 批准号:
    10697464
    10697464
  • 财政年份:
    2023
  • 资助金额:
    $ 48.83万
    $ 48.83万
  • 项目类别: